Half-year report · HY
4320.TEDINET S100Y26V
Period2025-10-01 → 2026-03-31
Filed2026-05-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.9bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥15.8bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.2bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥1.4bn | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.4bn | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.3bn | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥709m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥708m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥815m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥782m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥14.1bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥12.7bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥12.7bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.4bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥3.9bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥8.7bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.8bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.4bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.7bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.1bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.8bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.0bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥986m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥629m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥560m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥394m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥237m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥413m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥147m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥341m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥42.54 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.85 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.48 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.9% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.2% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥22m |
| Heathcare Solution Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥10.6bn |
| Heathcare Solution Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥10.6bn |
| Heathcare Solution Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥1.4bn |
| Marketing Solution Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥272m |
| Marketing Solution Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥272m |
| Marketing Solution Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥21m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥10.9bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥10.9bn |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | ¥3m |
| Heathcare Solution Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥8.9bn |
| Heathcare Solution Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥8.9bn |
| Heathcare Solution Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥1.2bn |
| Marketing Solution Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥317m |
| Marketing Solution Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥317m |
| Marketing Solution Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥32m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥9.2bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥9.2bn |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥1.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 490
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 8883240000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 316687000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 9199928000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1InterimDuration | 9199928000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 1196559000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 31856000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 1228416000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | 2545000 | JPY |
| Operating income | Prior1InterimDuration | 1230962000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 10605365000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 272069000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 10877435000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 10877435000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E05233-000MarketingSolutionBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 10605365000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 272069000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 10877435000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | InterimDuration | 10877435000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05233-000HeathcareSolutionBusinessReportableSegmentsMember | 1400227000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E05233-000MarketingSolutionBusinessReportableSegmentsMember | 21417000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | 1421645000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | -21764000 | JPY |
| Operating income | InterimDuration | 1399880000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)北海道財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-05-08 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第31期中(自 2025年10月１日 至 2026年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社ＣＥホールディングス | |
| Company name in english cover page | FilingDateInstant | CE Holdings Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 ＣＯＯ（最高執行責任者） 新里 雅則 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)札幌市白石区平和通十五丁目北１番21号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０１１（８６１）１６００（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 ＣＦＯ（最高財務責任者） 田口 常仁 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)札幌市白石区平和通十五丁目北１番21号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０１１（８６１）１６００（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 ＣＦＯ（最高財務責任者） 田口 常仁 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05233 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 43200 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |